Serum Ketone Bodies in Diabetic Ketoacidosis

Diabetic ketoacidosis (DKA) is a serious and potentially life-threatening condition frequently encountered in individuals with type 1 diabetes. It develops when insulin deficiency prompts the breakdown of fatty acids, leading to the production of ketone bodies and resulting in metabolic acidosis. Diagnosis of DKA relies on blood tests that reveal elevated serum levels of ketone bodies, such as acetoacetate and beta-hydroxybutyrate. Early detection and swift management, including fluid replacement and insulin therapy, are essential to prevent severe complications and restore metabolic balance. Recognizing the symptoms of DKA is crucial for ensuring timely intervention.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp